ONCOLOGY INSTITUTE INC/THE (TOI) Stock Price & Overview
NASDAQ:TOI • US68236X1000
Current stock price
The current stock price of TOI is 3.7 USD. Today TOI is up by 8.5%. In the past month the price increased by 35.86%. In the past year, price increased by 242.3%.
TOI Key Statistics
- Market Cap
- 365.708M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.52
- Dividend Yield
- N/A
TOI Stock Performance
TOI Stock Chart
TOI Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to TOI. When comparing the yearly performance of all stocks, TOI is one of the better performing stocks in the market, outperforming 97.75% of all stocks.
TOI Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to TOI. Both the profitability and financial health of TOI have multiple concerns.
TOI Earnings
On March 12, 2026 TOI reported an EPS of -0.06 and a revenue of 141.96M. The company beat EPS expectations (33.99% surprise) and beat revenue expectations (0.56% surprise).
TOI Forecast & Estimates
8 analysts have analysed TOI and the average price target is 6.63 USD. This implies a price increase of 79.19% is expected in the next year compared to the current price of 3.7.
For the next year, analysts expect an EPS growth of 42.22% and a revenue growth 27.09% for TOI
TOI Groups
Sector & Classification
TOI Financial Highlights
Over the last trailing twelve months TOI reported a non-GAAP Earnings per Share(EPS) of -0.52.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -33.41% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
TOI Ownership
TOI Latest News, Press Relases and Analysis
TOI Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| HCA | HCA HEALTHCARE INC | 17.17 | 117.443B | ||
| THC | TENET HEALTHCARE CORP | 12.83 | 19.07B | ||
| ENSG | ENSIGN GROUP INC/THE | 27.39 | 12.172B | ||
| UHS | UNIVERSAL HEALTH SERVICES-B | 8.26 | 11.819B | ||
| EHC | ENCOMPASS HEALTH CORP | 17.05 | 10.084B | ||
| PACS | PACS GROUP INC | 17.17 | 5.509B | ||
| BKD | BROOKDALE SENIOR LIVING INC | N/A | 3.372B | ||
| CON | CONCENTRA GROUP HOLDINGS PAR | 15.5 | 2.91B | ||
| NHC | NATIONAL HEALTHCARE CORP | N/A | 2.563B | ||
| ACHC | ACADIA HEALTHCARE CO INC | 16.26 | 2.101B | ||
| SEM | SELECT MEDICAL HOLDINGS CORP | 12.46 | 2.015B | ||
| SNDA | SONIDA SENIOR LIVING INC | N/A | 1.714B | ||
| SGRY | SURGERY PARTNERS INC | 16.75 | 1.603B |
Related stock screener links
View all stocks in the Health Care Facilities Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About TOI
Company Profile
The Oncology Institute, Inc. provides cancer care treatment services. The company is headquartered in Cerritos, California and currently employs 825 full-time employees. The company went IPO on 2020-03-13. The firm manages community-based oncology practices which serve patients at approximately 86 clinic locations across 16 markets and five states throughout the United States. The firm's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion, radiation, and programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. The firm also provides management services to over 14 clinic locations owned by independent oncology practices. The firm and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.
Company Info
IPO: 2020-03-13
ONCOLOGY INSTITUTE INC/THE
18000 Studebaker Rd, Suite 800
Cerritos CALIFORNIA US
CEO: Steven Hochberg
Employees: 825
Phone: 15627353226
ONCOLOGY INSTITUTE INC/THE / TOI FAQ
Can you describe the business of ONCOLOGY INSTITUTE INC/THE?
The Oncology Institute, Inc. provides cancer care treatment services. The company is headquartered in Cerritos, California and currently employs 825 full-time employees. The company went IPO on 2020-03-13. The firm manages community-based oncology practices which serve patients at approximately 86 clinic locations across 16 markets and five states throughout the United States. The firm's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion, radiation, and programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. The firm also provides management services to over 14 clinic locations owned by independent oncology practices. The firm and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.
Can you provide the latest stock price for ONCOLOGY INSTITUTE INC/THE?
The current stock price of TOI is 3.7 USD. The price increased by 8.5% in the last trading session.
Does ONCOLOGY INSTITUTE INC/THE pay dividends?
TOI does not pay a dividend.
What is the ChartMill technical and fundamental rating of TOI stock?
TOI has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Should I buy TOI stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on TOI.
What is the expected growth for TOI stock?
The Revenue of ONCOLOGY INSTITUTE INC/THE (TOI) is expected to grow by 27.09% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
Can you provide the number of employees for ONCOLOGY INSTITUTE INC/THE?
ONCOLOGY INSTITUTE INC/THE (TOI) currently has 825 employees.